[{"from": "human", "value": "Provide a description of this molecule. [C][C][=C][C][=Branch2][Ring2][P][=C][Branch2][Ring1][=N][C][=C][Ring1][=Branch1][C][=C][Branch2][Ring1][Ring1][N][=C][C][=Branch1][Ring2][=C][Ring1][=Branch1][C][=N][C][=Branch1][Ring2][=N][Ring1][#Branch1][N][C][C][N][C][=Branch1][C][=O][N][C][C][C][Branch1][C][C][Branch1][C][C][C][F]"}, {"from": "gpt", "value": "The molecule is an orally available inhibitor of all members of the serine/threonine protein kinase Raf family, including A-Raf, B-Raf and C-Raf protein kinases, with potential antineoplastic activity. Upon administration, pan-RAF kinase inhibitor LY3009120 inhibits Raf-mediated signal transduction pathways, which may inhibit tumor cell growth. Raf protein kinases play a key role in the RAF/mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK) signaling pathway, which is often dysregulated in human cancers and plays a key role in tumor cell proliferation and survival."}]